Myocardial Revascularization in Patients with Diabetes and Heart Failure-A Narrative Review

Stefan Zivkovic1, Aleksandar Mandic1, Kosta Krupnikovic1

  • 1Cardiology Clinic, Institute for Cardiovascular Diseases "Dedinje", 11000 Belgrade, Serbia.

Insights

Heart failure and diabetes mellitus significantly complicate myocardial revascularization. Understanding their interaction is crucial for improving outcomes in patients with coronary artery disease and these comorbidities.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Heart failure and diabetes mellitus are prevalent, chronic conditions with increasing incidence.
  • These diseases frequently coexist, exacerbating cardiovascular risk and complicating management.
  • Coronary artery disease is common in patients with heart failure and diabetes, posing challenges for myocardial revascularization.

Purpose of the Study:

  • To review the mechanisms underlying revascularization failure in patients with coexisting heart failure and diabetes mellitus.
  • To analyze evidence from randomized controlled trials regarding revascularization in this complex patient population.
  • To highlight the importance of understanding these interactions for optimizing treatment strategies.

Main Methods:

  • Narrative review of existing literature and randomized controlled trials.
  • Analysis of mechanisms contributing to revascularization failure.
  • Examination of evidence in general and specific patient subgroups.

Main Results:

  • Diabetes mellitus accelerates atherosclerosis and impairs endothelial function, impacting revascularization success.
  • Heart failure complicates myocardial perfusion and recovery post-intervention.
  • Evidence from trials in general and specific subgroups (elderly, left main disease, CKD, PAD, COPD) was examined.

Conclusions:

  • The interplay between heart failure, diabetes, and coronary artery disease significantly affects revascularization outcomes.
  • A comprehensive understanding of these pathophysiological mechanisms is essential for effective clinical management.
  • Optimizing treatment strategies requires consideration of these complex interactions to improve patient prognosis.